Neurocrine Biosciences, Inc. (NASDAQ:NBIX) was in 16 hedge funds' portfolio at the end of the first quarter of 2013. NBIX has experienced an increase in hedge fund sentiment recently.
Market Vectors Gold Miners ETF (NYSEARCA:GDX) – Big prints in Market Vectors Gold Miners ETF (NYSEARCA:GDX) put options on Tuesday morning indicate some traders are positioning for shares in the Market...
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds' portfolio at the end of the fourth quarter of 2012. AEGR has seen an increase in hedge fund sentiment in recent months.
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) was in 14 hedge funds' portfolio at the end of December. AEGR has experienced an increase in enthusiasm from smart money in recent months.
Pacira Pharmaceuticals Inc (NASDAQ:PCRX) was in 9 hedge funds' portfolio at the end of December. PCRX shareholders have witnessed a decrease in hedge fund interest lately.